1,364 results on '"Lucas, Philippe"'
Search Results
2. Changed Substance Use After Psychedelic Experiences Among Individuals in Canada
3. The Global Psychedelic Survey: Consumer characteristics, patterns of use, and access in primarily anglophone regions around the world
4. A small clinical trial of vaporized cannabis for PTSD: suggestive results and directions for future study
5. Anatomy and Functioning of the Insect Chemosensory System
6. Semiochemicals and Communication in Insects
7. Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: the Canadian context
8. Stimulus duration encoding occurs early in the moth olfactory pathway.
9. Perspectives on Healing and Recovery from Addiction with Ayahuasca-Based Therapy Among Members of an Indigenous Community in Canada
10. Medical Cannabis for Patients Over Age 50: A Multi-site, Prospective Study of Patterns of Use and Health Outcomes
11. Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada
12. Self-reported reductions in tobacco and nicotine use following medical cannabis initiation: Results from a cross-sectional survey of authorized medical cannabis patients in Canada
13. Un estudi de la fragilitat de la cadena de valor global dels xips o semiconductors
14. Mechanical design of a shoulder rehabilitation machine for elderly people regarding system safety standards.
15. Reductions in alcohol use following medical cannabis initiation: results from a large cross-sectional survey of medical cannabis patients in Canada
16. Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey
17. The impact of non-medical cannabis legalization and other exposures on retention in longitudinal cannabis research: a survival analysis of a prospective study of Canadian medical cannabis patients
18. Light-Weight Portable Electroantennography Device as a Future Field-Based Tool for Applied Chemical Ecology
19. Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users
20. A high-throughput screen for the identification of compounds that inhibit nematode gene expression by targeting spliced leader trans-splicing
21. The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs
22. Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada
23. Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients
24. Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients
25. mTORC1 Balances Cellular Amino Acid Supply with Demand for Protein Synthesis through Post-transcriptional Control of ATF4
26. Changed Substance Use After Psychedelic Experiences Among Individuals in Canada
27. A tale of two copies: Evolutionary trajectories of moth pheromone receptors
28. Changements observés au Canada dans la consommation de cannabis à des fins médicales pendant la pandémie de COVID-19
29. Shifts in medical cannabis use in Canada during the COVID-19 pandemic
30. The theoretical study of collaboration and cooperation in the fashion industry
31. The effect of pure oxygen supply on the performance of a downflow hanging sponge (DHS) system on municipal wastewater treatment
32. Sensorless torque estimation and control in a 1 DoF geared robotic arm
33. La planta catalana de Nissan: motivos que llevaron a su cierre
34. Low doses of a neonicotinoid insecticide modify pheromone response thresholds of central but not peripheral olfactory neurons in a pest insect
35. The Relationship Between Naturalistic Psychedelic Use and Clinical Care in Canada.
36. Firing and intrinsic properties of antennal lobe neurons in the Noctuid moth Agrotis ipsilon
37. A common public health-oriented policy framework for cannabis, alcohol and tobacco in Canada?
38. Barriers to access for Canadians who use cannabis for therapeutic purposes
39. Protocol for aerial trapping and analyses of candidate pheromone compounds released by moths via gas chromatography-mass spectrometry
40. Identification des COV actifs chez les femelles Eurytoma amygdali
41. Une approche « push » : premiers pas pour identifier des composés volatils pour repousser Psylliodes chrysocephala à distance
42. COV de l'amandier : discrimination des émissions au printemps pour la mise au point d'un mélange attractif du ravageur Eurytoma amygdali
43. Insect odorant receptors: promising targets for artificial nose
44. Electroantennography of terpene volatile compounds with insecticidal activity
45. Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
46. Diseases caused by soil-borne pathogens
47. Stimulus duration encoding occurs early in the moth olfactory pathway
48. Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use
49. Experimental analysis of multiaxial moment sensing techniques
50. OEE improvement in a nutraceutical stick-pack packaging line
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.